- A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribingHas a wanted fugitive been posing as a biotech executive? And what does it take to develop a therapy for an ultra-rare disease? Find out on this week's episode of…STAT · 6d ago↗ source
- STAT+: Vote on key federal health nominee delayed amid questions over vaccine viewsSean Kaufman, nominated to run ASPR, has a track record of questioning the safety of vaccines.STAT · 6d ago↗ source
- Biogen counts on drugs from Apellis deal to patch Leqembi's slow salesIt’s no secret that sales of Leqembi have been disappointing. First approved in 2023, the Alzheimer’s drug from Eisai and Biogen launched shortly after Chris Viehbacher took the reins as Biogen CEO…